Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine and Lidocaine Infusion for Refractory Chronic Migraine: Comparative Study

NCT06935552 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06935552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06935552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine and Lidocaine Infusion for Refractory Chronic Migraine: Comparative Study
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
December 31, 2026
Enrollment
44 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

refractory chronic migraine